Mesalamine for Colorectal Cancer Prevention Program in Lynch Syndrome

NCT04920149 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

150

Enrollment

OTHER

Sponsor class

Conditions

Lynch Syndrome
Colon Cancer
Colon Neoplasm

Interventions

DRUG: Mesalamine
DRUG: Placebo

Sponsor

Ann-Sofie Backman

Collaborators

[object Object]
[object Object]